Literature DB >> 16936211

Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice.

Shu-lian Li1, Marpadga A Reddy, Qiangjun Cai, Li Meng, Hang Yuan, Linda Lanting, Rama Natarajan.   

Abstract

Diabetes is associated with enhanced inflammatory responses and cardiovascular complications such as atherosclerosis. However, it is unclear whether similar responses are present in cells derived from experimental animal models of diabetes. We examined our hypothesis that macrophages and short-term cultured vascular smooth muscle cells (VSMCs) derived from obese, insulin-resistant, and diabetic db/db mice would exhibit increased proatherogenic responses relative to those from control db/+ mice. We observed that macrophages from db/db mice exhibit significantly increased expression of key inflammatory cytokines and chemokines as well as arachidonic acid-metabolizing enzymes cyclooxygenase-2 and 12/15-lipoxygenase that generate inflammatory lipids. Furthermore, VSMCs derived from db/db mice also showed similar enhanced expression of inflammatory genes. Expression of inflammatory genes was also significantly increased in aortas derived from db/db mice. Both macrophages and VSMCs from db/db mice demonstrated significantly increased oxidant stress, activation of key signaling kinases, and transcription factors cAMP response element-binding protein and nuclear factor-kappaB, involved in the regulation of atherogenic and inflammatory genes. Interestingly, VSMCs from db/db mice displayed enhanced migration as well as adhesion to WEHI mouse monocytes relative to db/+. Thus, the diabetic milieu and a potential hyperglycemic memory can induce aberrant behavior of vascular cells. These new results demonstrate that monocyte/macrophages and VSMCs derived from db/db mice display a "preactivated" and proinflammatory phenotype associated with the pathogenesis of diabetic vascular dysfunction and atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936211     DOI: 10.2337/db06-0164

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  59 in total

Review 1.  Epigenetic programming and risk: the birthplace of cardiovascular disease?

Authors:  Maria Cristina Vinci; Gianluca Polvani; Maurizio Pesce
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

2.  Autacoid 14S,21R-dihydroxy-docosahexaenoic acid counteracts diabetic impairment of macrophage prohealing functions.

Authors:  Haibin Tian; Yan Lu; Shraddha P Shah; Song Hong
Journal:  Am J Pathol       Date:  2011-08-10       Impact factor: 4.307

Review 3.  Vascular Smooth Muscle as a Target for Novel Therapeutics.

Authors:  Karen E Porter; Kirsten Riches
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

Review 4.  Epigenetic mechanisms in diabetic vascular complications.

Authors:  Marpadga A Reddy; Rama Natarajan
Journal:  Cardiovasc Res       Date:  2011-01-25       Impact factor: 10.787

Review 5.  The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease.

Authors:  Simon W Rabkin
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2009-03

6.  Class A scavenger receptor-mediated macrophage adhesion requires coupling of calcium-independent phospholipase A(2) and 12/15-lipoxygenase to Rac and Cdc42 activation.

Authors:  Dejan M Nikolic; Ming C Gong; John Turk; Steven R Post
Journal:  J Biol Chem       Date:  2007-09-15       Impact factor: 5.157

Review 7.  Epigenetic mechanisms in diabetic complications and metabolic memory.

Authors:  Marpadga A Reddy; Erli Zhang; Rama Natarajan
Journal:  Diabetologia       Date:  2014-12-07       Impact factor: 10.122

8.  Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiation.

Authors:  Li Meng; Jehyun Park; Qiangjun Cai; Linda Lanting; Marpadga A Reddy; Rama Natarajan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

Review 9.  Diabetic keratopathy: Insights and challenges.

Authors:  S Priyadarsini; A Whelchel; S Nicholas; R Sharif; K Riaz; D Karamichos
Journal:  Surv Ophthalmol       Date:  2020-02-22       Impact factor: 6.048

10.  Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy.

Authors:  Hang Yuan; Marpadga A Reddy; Supriya Deshpande; Ye Jia; Jung Tak Park; Linda L Lanting; Wen Jin; Mitsuo Kato; Zhong Gao Xu; Sadhan Das; Rama Natarajan
Journal:  Antioxid Redox Signal       Date:  2015-11-30       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.